title: Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system.
authors.affiliation: M. D. Anderson Hospital, University of Texas System Cancer Center, Houston.
authors.forename: J B
authors.initials: JB
authors.lastname: Blacklock
authors.forename: E A
authors.initials: EA
authors.lastname: Grimm
mesh_terms: D001932:Brain Neoplasms / Q000628:therapy*; D005910:Glioma / Q000628:therapy; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*
chemical_list: D007376:Interleukin-2